Merchant, M., Moffat, J., Schaefer, G., Chan, J., Wang, X., Orr, C., . . . Junttila, M. R. (2017). Combined MEK and ERK inhibition overcomes therapy-mediated pathway reactivation in RAS mutant tumors. PLoS One.
Dyfyniad Arddull ChicagoMerchant, Mark, et al. "Combined MEK and ERK Inhibition Overcomes Therapy-mediated Pathway Reactivation in RAS Mutant Tumors." PLoS One 2017.
Dyfyniad MLAMerchant, Mark, et al. "Combined MEK and ERK Inhibition Overcomes Therapy-mediated Pathway Reactivation in RAS Mutant Tumors." PLoS One 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.